FoxFeed Blog
Latest Blog Posts Tagged "Podcast"
Podcast: Putting the Parkinson's Puzzle Together
August 08, 2018
One of our MJFF scientists talks about piecing together the many factors that play a role in Parkinson's and what can help us continue making progress.
New Podcast on Parkinson's, Gaucher and GBA
August 03, 2018
A podcast from the National Gaucher Foundation covers the genetic connection between Parkinson's and Gaucher diseases and new treatments in the works.
Podcast: What Is a Protein Anyway?
May 04, 2018
MJFF scientist Dr. Brian Fiske talks about what goes wrong with cellular proteins, how we may fix them and if you should eat less protein.
Podcast: Addressing a Parkinson's Pandemic
March 13, 2018
Dr. Ray Dorsey from the University of Rochester discusses the rise in Parkinson's and how we can take steps to prevent onset and get people the care they need.
Podcast: 2017 Parkinson's Research Year in Review
December 22, 2017
Missed our Year in Review webinar? Catch up with this recording and hear our panelists recap new potential Parkinson's treatments in clinical testing.
Podcast: Cells' Recycling System
December 15, 2017
Autophagy is how cells break down and recycle damaged parts. We explain the link to Parkinson's and how treating autophagy may slow or stop disease.
Podcast: Your Day Is Our Data
November 13, 2017
The online study Fox Insight analyzes data on life with disease from tens of thousands of people, with or without PD, to influence research focus and design.
Podcast: Sniff Test for Parkinson's Disease
October 17, 2017
Measuring a person's scent or eye movements could lead to earlier PD diagnosis.
Podcast: Measuring Feeling and Functional Impact of Dyskinesia
September 20, 2017
How does dyskinesia impact people with PD? An MJFF-funded measurement scale captured those perceptions and helped a new drug get approved to treat it.
Podcast: Teaching Old Drugs New Tricks
July 17, 2017
Scientists are testing drugs used for high blood pressure and diabetes for their effects on Parkinson's disease. MJFF CEO Todd Sherer, PhD, discusses this tactic of drug repurposing.
Popular Topics
